NMNAT2 and early-onset autosomal dominant Alzheimer disease: nmnat2 mRNA levels are reduced in Parkinson, Huntington, and Alzheimer diseases (AD), as well as in tauopathies [26–31], suggesting a role of NMNAT2 in maintaining neuronal health in the aging brain.